The present invention relates generally to cardiac catheters, and more particularly, to a transseptal insertion device which is suitable for facilitating quick and safe transseptal puncture and insertion of a needle or catheter through a cardiac septum to provide access to the left atrium in implementation of a left atrial intervention.
Cardiac catheterization is a medical procedure in which a long thin tube or catheter is inserted through an artery or vein into specific areas of the heart for diagnostic or therapeutic purposes. More specifically, cardiac chambers, vessels and valves may be catheterized.
Cardiac catheterization may be used in procedures such as coronary angiography and left ventricular angiography. Coronary angiography facilitates visualization of the coronary vessels and finding of potential blockages by taking X-ray images of a patient who has received a dye (contrast material) injection into a catheter previously injected in an artery. Left ventricular angiography enables examination of the left-sided heart chambers and the function of the left-sided valves of the heart, and may be combined with coronary angiography. Cardiac catheterization can also be used to measure pressures throughout the four chambers of the heart and evaluate pressure differences across the major heart valves. In further applications, cardiac catheterization can be used to estimate the cardiac output, or volume of blood pumped by the heart per minute.
Some medical procedures may require catheterization into the left atrium of the heart. For this purpose, in order to avoid having to place a catheter in the aorta, access to the left atrium is generally achieved by accessing the right atrium, puncturing the interatrial septum between the left and right atria of the heart, and threading the catheter through the septum and into the left atrium. Transseptal puncture must be carried out with extreme precision, as accidental puncturing of surrounding tissue may cause very serious damage to the heart. In addition, transseptal puncture may require complicated instruments which are not helpful in guaranteeing the precision of the puncture.
Accordingly, there is an established need for a device that is suitable for facilitating quick and safe transseptal puncturing to provide access to the left atrium in implementation of a left atrial intervention.
It is an object of the present invention to provide a device that is suitable for facilitating quick and safe transseptal puncturing to provide access to the left atrium in implementation of a left atrial intervention.
The present invention is directed to a transseptal insertion device which is suitable for facilitating quick and safe transseptal insertion of a needle or catheter through an interatrial cardiac septum to provide access to the left atrium in implementation of a left atrial intervention. The transseptal insertion device is elongated yet has a relatively reduced length, and can be easily and safely turned within an atrium of the heart to achieve a correct orientation towards the cardiac septum.
Introducing a first implementation of the invention, the present invention includes a transseptal insertion device which is suitable for facilitating a precise and safe transseptal insertion of a needle or catheter through a cardiac septum, comprising a device housing and a slidable body slidably disposed in the device housing. The slidable body includes a pusher and a guide element extending from the pusher. The guide element us extendable and retractable from a distal end of the device housing.
In a second aspect, the guide element may be formed as a web.
In another aspect, the device housing may include a housing interior and an annular housing gap surrounding the housing interior, and the guide element may be slidably disposed within the housing gap.
In another aspect, the device housing may include an outer housing wall, an inner housing wall, a housing interior formed by the inner housing wall and an annular housing gap surrounding the housing interior.
In still another aspect, the pusher may include a front pusher ring, a rear pusher ring spaced-apart from the front pusher ring and at least one pusher rod extending between the front pusher ring and the rear pusher ring.
In yet another aspect, the one or more pusher rods may extend between the front pusher ring and the rear pusher ring.
In another aspect, the guide element may extend from the front pusher ring of the pusher.
In another aspect, the guide element may include multiple, parallel, spaced-apart longitudinal webbing elements and multiple, annular transverse webbing elements provided at spaced-apart intervals with respect to each other along the longitudinal webbing elements.
In another aspect, multiple anchors may terminate the respective longitudinal webbing elements of the guide element for impingement against the cardiac septum in insertion of a needle or catheter through an orifice in the septum.
In another aspect, at least one of the pusher and the guide element can be inflatable.
In another aspect, the device housing can include an outer housing wall defining a housing interior and a pusher channel extending through the outer housing wall generally parallel and adjacent to the housing interior. The guide element can further include a pusher having an inflatable pusher rod slidably disposed in the pusher channel and an inflatable pusher ring terminating and disposed in fluid communication with the pusher rod.
These and other objects, features, and advantages of the present invention will become more readily apparent from the attached drawings and the detailed description of the preferred embodiments, which follow
Objects of the invention and its particular features and advantages will become more apparent from consideration of the following drawings and accompanying detailed description. It should be understood that the detailed description and specific examples, while indicating the preferred embodiment of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
The preferred embodiments of the invention will hereinafter be described in conjunction with the appended drawings provided to illustrate and not to limit the invention, where like designations denote like elements, and in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
In the following description, numerous details are set forth for the purpose of example and explanation; however, one of ordinary skill in the art will realize that the invention may be practiced without the use of these specific details.
The following detailed description is merely exemplary in nature and is not intended to limit the described embodiments or the application and uses of the described embodiments. As used herein, the word “exemplary” or “illustrative” means “serving as an example, instance, or illustration.” Any implementation described herein as “exemplary” or “illustrative” is not necessarily to be construed as preferred or advantageous over other implementations. All of the implementations described below are exemplary implementations provided to enable persons skilled in the art to make or use the embodiments of the disclosure and are not intended to limit the scope of the disclosure, which is defined by the claims. For purposes of description herein, the terms “upper”, “lower”, “left”, “rear”, “right”, “front”, “vertical”, “horizontal”, and derivatives thereof shall relate to the invention as oriented in
Shown throughout the figures, the present invention is directed toward a transseptal insertion device which is suitable for facilitating quick and safe transseptal puncturing of an interatrial septum and insertion of a catheter therethrough to provide access to the left atrium in implementation of a left atrial intervention.
Referring initially to
Further, the transseptal insertion device 100 includes a slidable body 120 which is arranged inside the device housing 102 and slidably or longitudinally translatable relative to the device housing 102. The slidable body 120 of the present embodiment is composed of a pusher 122 and a webbed guide element 132. In some embodiments, the slidable body 120, such as the pusher 122 and webbed guide element 132, can be formed into a single-piece unit such as by injection molding, welding or the like.
In certain embodiments, the slidable body 120 is covered with fabric such as PTFE/Dacron which makes it non-porous.
As best shown in
With continued reference to
As shown in
For purposes that will be described hereinafter, the slidable body is used to anchor into the left atrial appendage in the eventuality of a perforation during a left atrial appendage procedure. Since it is non-porous, it will act as an occlusion balloon and prevent further extravasation of blood in the pericardial sac till a more definitive procedure may be performed or the bleeding stops
For purposes that will be described hereinafter, a catheter 500 carrying a spear or needle can be inserted through the transseptal insertion device 100 and, guided by the slidable body 120, protrude outwardly from the distal end 112 of the device housing 102 as shown in
In certain embodiments, the slidable body is used to remove an implanted mitral regulation (Mitraclip®) device. The slidable body is used to anchor onto the anterior and posterior leaflets of the mitral valve. Once anchored, there is either a mechanical, magnetic or electromagnetic lever that attaches to the mitral regulation device and stabilizes it. Energy is then delivered to the mitral valve to via the slidable body 120 to ablate the anterior and posterior leaflets. The mitral regulation device is thereby released and removed from the body. The slidable body 120 may also be used in the absence of a mitral regulation device on the mitral valve and may be used to ablate the anterior mitral leaflet prior to mitral valve implantation to prevent left ventricular outflow tract obstruction. In this instance, the anterior mitral leaflet would be stabilized with a set of stabilizers which would be housed within the slidable body 120. The stabilizers would be used to stabilize the anterior mitral leaflet first and then the slidable body would be used to deliver energy to ablate the anterior mitral leaflet. The ablated tissue would then be removed from the body using the stabilizer.
In certain embodiments, the slidable body is used to anchor into the pulmonary veins. Radiofrequency energy or other forms of energy may be delivered via the cable and the slidable body to the pulmonary veins to result in electrical ablation.
A typical application of the transseptal insertion device 100 to puncture the interatrial cardiac septum 520 is now described with reference to
Initially, the transseptal insertion device 100 is arranged in the retracted or first position (described heretofore with reference to
Once the transseptal insertion device 100 reaches the right atrium 510, a second, separate catheter 500 carrying a spear or needle (not shown) therewithin is extended through the slidable body 120 and the housing interior 110 of the device housing 102. The catheter 500 may have a conventional design with an elongated, typically flexible catheter body 502 and a tapered catheter tip 504 which terminates the catheter body 502. Before or after inserting the second, separate catheter 500 into the transseptal insertion device 100, the surgeon slowly moves the transseptal insertion device 100 to place it near, and facing, a target point. 522 or area of the cardiac septum 520 to be punctured, as shown in
Once the transseptal insertion device 100 is arranged facing the target point 522 of the cardiac septum 520, the transseptal insertion device 100 is operated to switch from the retracted position of
Once the webbed guide element 132 rests on the cardiac septum 520, the webbed guide element 132 and cardiac septum 520 enclose the internal space 133 of the webbed guide element 132 and the target point 522 of the cardiac septum 520. The spear or needle may then be advanced through the catheter 500 and towards the cardiac septum 520, puncturing the cardiac septum 520 and forming an orifice 530 in the cardiac septum 520. The slidable body 120 being arranged in the housing gap 108 between the outer housing wall 104 and the inner housing wall 106 of the device housing 102 contributes to stabilize the slidable body 120, and thus to maintain the webbed guide element 132 in a same position, providing a safe and precise aim when puncturing the cardiac septum 520.
Having created an orifice 530 in the cardiac septum 520, the catheter 500 may then be inserted through the orifice 530 and into the left atrium 512 of the patient's heart in order to proceed with the left atrium intervention as known in the art. The transseptal insertion device 100 may be maintained in the position of
After the cardiac catheterization procedures are completed, the catheter 500 may be withdrawn from the left atrium 512 through the orifice 530 and retracted back into the webbed guide element 132. Next, the webbed guide element 132 may be withdrawn from engagement with the cardiac septum 520 and into the housing gap 108, as illustrated in
It will be appreciated by those skilled in the art that the transseptal insertion device 100 facilitates safer and quicker insertion of the spear or needle and the catheter 500 through the cardiac septum 520, and thus, quicker and safer access to the left atrium 512, minimizing the risk of damaging surrounding tissue during insertion of the needle or catheter 500.
Referring next to
Similarly to the previous embodiment, as illustrated in
Similarly to the previous embodiment, as shown in
A typical application of the transseptal insertion device 200 to puncture the interatrial cardiac septum 520 is now described with reference to
Initially, the transseptal insertion device 200 is arranged in the retracted or first position (described heretofore with reference to
Once the transseptal insertion device 200 reaches the right atrium 510, a second, separate catheter 500 carrying a spear or needle (not shown) therewithin is extended through the slidable body 220 and the housing interior 210 of the device housing 202. The catheter 500 may have a conventional design with an elongated, typically flexible catheter body 502 and a tapered catheter tip 504 which terminates the catheter body 502. Before or after inserting the second, separate catheter 500 into the transseptal insertion device 200, the surgeon slowly moves the transseptal insertion device 200 to place it near, and facing, a target point 522 or area of the cardiac septum 520 to be punctured, as shown in
Once the transseptal insertion device 200 is arranged facing the target point 522 of the cardiac septum 520, the transseptal insertion device 200 is operated to switch from the retracted position of
Once the annular guide element 232 rests on the cardiac septum 520, the annular guide element 232 and cardiac septum 520 enclose the internal space 233 of the webbed guide element 232 and the target point 522 of the cardiac septum 520. The spear or needle may then be advanced through the catheter 500 and towards the cardiac septum 520, puncturing the cardiac septum 520 and forming an orifice 530 in the cardiac septum 520.
Having created an orifice 530 in the cardiac septum 520, the catheter 500 may then be inserted through the orifice 530 and into the left atrium 512 of the patient's heart in order to proceed with the left atrium intervention as known in the art. The transseptal insertion device 200 may be maintained in the position of
After the cardiac catheterization procedures are completed, the catheter 500 may be withdrawn from the left atrium 512 through the orifice 530 and retracted back into the webbed guide element 232. Next, the annular guide element 232 may be withdrawn from engagement with the cardiac septum 520 and into the housing gap 208, as illustrated in
Referring next to
In certain embodiments, the device includes a front-facing ultrasound transducer and/or a side-facing ultrasound transducer. In certain embodiments, the front-facing ultrasound transducer and/or a side-facing ultrasound transducer include a chip or ultrasound chip designed to convey and store electronic signals from the ultrasound transducer.
Referring next to
The transseptal insertion device of the present invention can successfully assist the surgeon in carrying out at least one of the following techniques: visualization and stabilization of the intra atrial septum; visualization and stabilization of the fossa ovalis; guidance for transseptal puncture and across septum into safe zone of left atrium (away from structures such as aorta); guidance into the left atrium (for isolation of pulmonary veins for AFib ablation); visualization of the left atrium; guidance into the pulmonary veins; visualization and stabilization of the pulmonary veins, and more specifically of the ostium of the pulmonary veins; visualization and stabilization of the left atrial appendage; guidance into the left atrial appendage; visualization and stabilization of the mitral valve; and guidance into the mitral valve and left ventricle.
Since many modifications, variations, and changes in detail can be made to the described preferred embodiments of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
Number | Name | Date | Kind |
---|---|---|---|
4696304 | Chin | Sep 1987 | A |
4813934 | Engelson et al. | Mar 1989 | A |
5135001 | Sinofsky et al. | Aug 1992 | A |
5295958 | Shturman | Mar 1994 | A |
5699805 | Seward et al. | Dec 1997 | A |
5792118 | Kurth et al. | Nov 1998 | A |
5865801 | Houser | Feb 1999 | A |
6017323 | Chee | Jan 2000 | A |
6102907 | Smethers et al. | Aug 2000 | A |
6102926 | Targalia et al. | Aug 2000 | A |
6129672 | Seward et al. | Oct 2000 | A |
6231588 | Zadno-azizi | May 2001 | B1 |
6440097 | Kupiecki | Aug 2002 | B1 |
6540712 | Parodi et al. | Apr 2003 | B1 |
7666203 | Chanduszko et al. | Feb 2010 | B2 |
7678081 | Whiting et al. | Mar 2010 | B2 |
8096959 | Stewart et al. | Jan 2012 | B2 |
8900214 | Nance et al. | Dec 2014 | B2 |
9072872 | Asleson et al. | Jul 2015 | B2 |
9510904 | Krishnan | Dec 2016 | B2 |
9545265 | Maisano et al. | Jan 2017 | B2 |
9700351 | Maisano et al. | Jul 2017 | B2 |
9757137 | Krolik et al. | Sep 2017 | B2 |
20030019546 | Kanekiyo et al. | Jan 2003 | A1 |
20030023204 | Vo et al. | Jan 2003 | A1 |
20030229386 | Rosenman et al. | Dec 2003 | A1 |
20040215233 | Kaplan et al. | Oct 2004 | A1 |
20050065419 | Partridge et al. | Mar 2005 | A1 |
20050159738 | Visram et al. | Jul 2005 | A1 |
20050197530 | Wallace | Sep 2005 | A1 |
20050245822 | Dala-Krishna et al. | Nov 2005 | A1 |
20060009715 | Khairkhahan et al. | Jan 2006 | A1 |
20070149995 | Quinn et al. | Jun 2007 | A1 |
20070270751 | Stangenes et al. | Nov 2007 | A1 |
20070293724 | Saadat | Dec 2007 | A1 |
20080132937 | Hartley | Jun 2008 | A1 |
20080171989 | Bell | Jul 2008 | A1 |
20080243081 | Nance | Oct 2008 | A1 |
20080262596 | Xiao | Oct 2008 | A1 |
20090076498 | Saadat et al. | Mar 2009 | A1 |
20090259272 | Reddy et al. | Oct 2009 | A1 |
20100010488 | Kassab | Jan 2010 | A1 |
20100168777 | Stangenes et al. | Jul 2010 | A1 |
20100174189 | Abraham | Aug 2010 | A1 |
20100286718 | Kassab | Nov 2010 | A1 |
20110270239 | Werneth | Nov 2011 | A1 |
20110295268 | Roelle | Dec 2011 | A1 |
20120203169 | Tegg | Aug 2012 | A1 |
20120259263 | Celermajer | Oct 2012 | A1 |
20130090649 | Smith | Apr 2013 | A1 |
20130102862 | Mercader | Apr 2013 | A1 |
20140039494 | Kick et al. | Feb 2014 | A1 |
20140081301 | Tran | Mar 2014 | A1 |
20140171903 | Roman et al. | Jun 2014 | A1 |
20140276027 | Gaddis | Sep 2014 | A1 |
20140309675 | Maisano et al. | Oct 2014 | A1 |
20150165170 | Beasley et al. | Jun 2015 | A1 |
20150173794 | Kurth | Jun 2015 | A1 |
20150217093 | Tsutsui et al. | Jun 2015 | A1 |
20150216620 | Davies et al. | Aug 2015 | A1 |
20150224240 | Farnan et al. | Aug 2015 | A1 |
20150258270 | Kunis | Sep 2015 | A1 |
20150306359 | Drasler | Oct 2015 | A1 |
20160008636 | Warnking | Jan 2016 | A1 |
20160051321 | Salahieh et al. | Feb 2016 | A1 |
20160081704 | Jeon | Mar 2016 | A1 |
20160100860 | Lenker et al. | Apr 2016 | A1 |
20160143522 | Ransbury et al. | May 2016 | A1 |
20160193449 | Sarabia et al. | Jul 2016 | A1 |
20160279393 | Anderson et al. | Sep 2016 | A1 |
20170105761 | Sapir et al. | Apr 2017 | A1 |
20170135559 | Horrisberger et al. | May 2017 | A1 |
20170143940 | Flygare | May 2017 | A1 |
20180103985 | Maini | Apr 2018 | A1 |
20180177516 | Vardi | Jun 2018 | A1 |
20180264231 | Scheibe et al. | Sep 2018 | A1 |
20190000544 | Govari et al. | Jan 2019 | A1 |
20190029722 | Maini | Jan 2019 | A1 |
20190029750 | Maini | Jan 2019 | A1 |
20190134412 | Shuros et al. | May 2019 | A1 |
20190209177 | Whitfield et al. | Jul 2019 | A1 |
20200297412 | Maini | Sep 2020 | A1 |
20200390495 | Maini | Dec 2020 | A1 |
20210085384 | Maini | Mar 2021 | A1 |
20210100981 | Maini et al. | Aug 2021 | A1 |
20210251553 | Maini | Aug 2021 | A1 |
Number | Date | Country |
---|---|---|
2018307956 | Feb 2020 | AU |
2018307969 | Feb 2020 | AU |
2020241992 | Oct 2021 | AU |
3041032 | Apr 2018 | CA |
3071391 | Jan 2019 | CA |
3071432 | Jan 2019 | CA |
3151548 | Mar 2021 | CA |
2019001078 | Nov 2019 | CL |
2020000232 | Feb 2021 | CL |
1599579 | Mar 2005 | CN |
101442946 | May 2009 | CN |
103429179 | Dec 2013 | CN |
107530532 | Jan 2018 | CN |
110022779 | Jul 2019 | CN |
111093539 | May 2020 | CN |
111148474 | May 2020 | CN |
114727804 | Jul 2022 | CN |
2233169 | Sep 2010 | EP |
2459266 | Jun 2012 | EP |
3658036 | Mar 2020 | EP |
3253438 | Sep 2022 | EP |
202017008345 | Oct 2020 | IN |
H06506853 | Aug 1994 | JP |
H08117232 | May 1996 | JP |
2009539575 | Nov 2009 | JP |
2013226429 | Nov 2013 | JP |
2020530372 | Oct 2020 | JP |
2020530373 | Oct 2020 | JP |
02096264 | Dec 2002 | WO |
2007147060 | Dec 2007 | WO |
2014036317 | Mar 2014 | WO |
2015058007 | Apr 2015 | WO |
2017083785 | May 2017 | WO |
2018033401 | Feb 2018 | WO |
2018075426 | Apr 2018 | WO |
2019023609 | Jan 2019 | WO |
2019023653 | Jan 2019 | WO |
2019113043 | Jun 2019 | WO |
2020191133 | Sep 2020 | WO |
2020251999 | Dec 2020 | WO |
2021055572 | Mar 2021 | WO |
Entry |
---|
International Search Report PCT/US2017/056843 Completed: Nov. 20, 2017; dated Dec. 14, 2017 4 pages. |
Written Opinion of the International Searching Authority PCT/US2017/056843 dated Dec. 14, 2017 6 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2018/044143 dated Dec. 5, 2018, 16 sheets. |
International Search Report and Written Opinion for International Application No. PCT/US2018/044207 dated Oct. 31, 2018, 17 sheets. |
International Search Report and Written Opinion for International Application No. PCT/US2020/023518 dated Jun. 23, 2020, 15 sheets. |
The extended European search report dated May 12, 2020, from EP Application No. 17862286.6, 8 sheets. |
International Search Report and Written Opinion for International Application No. PCT/US2020/036965 dated Sep. 16, 2020, 16 sheets. |
Non-Final Office Action dated Apr. 30, 2021, from U.S. Appl. No. 16/047,910, 46 sheets. |
International Search Report and Written Opinion for International Application No. PCT/US2020/051228 dated Dec. 1, 2020, 14 sheets. |
Invitation to Respond to Written Opinion from Singapore Patent Application No. 11202000666S, dated Mar. 2, 2021, 11 sheets. |
Invitation to Respond to Written Opinion from Singapore Patent Application No. 11202000667S, dated Mar. 2, 2021, 11 sheets. |
First Office Action dated May 7, 2021, from Chinese Application No. 201780074077.5, 15 sheets. |
Written Opinion dated Jun. 16, 2021, from Chilean Patent Application N° 202000403, 16 sheets. |
International Search Report and Written Opinion dated May 25, 2021, from International Patent Application No. PCT/US2021/017528, 15 sheets. |
International Search Report and Written Opinion dated Jan. 13, 2021, from PCT/US2020/53902, 12 sheets. |
Communication Pursuant to Article 94(3) EPC dated Aug. 25, 2021, from EP Application No. 18755361.5, 4 sheets. |
Office Action dated Sep. 3, 2021, from Chile Application No. 202000232, 20 sheets. |
Notice of Reasons for Rejection dated Sep. 28, 2021, from Japanese Application No. 2019-521811, 4 sheets. |
International Search Report and Written Opinion dated Oct. 1, 2021, from PCT Application No. PCT/US2021/018409, 17 sheets. |
International Preliminary Report on Patentability PCT/US2017/056843; dated May 2, 2019, 5 pages. |
International Preliminary Report on Patentability PCT/US2018/044207; dated Feb. 6, 2020, 8 pages. |
International Preliminary Report on Patentability PCT/US2018/044143; dated Feb. 28, 2020, 9 pages. |
International Preliminary Report on Patentability PCT/US2020/023518; dated Sep. 30, 2021, 10 pages. |
International Preliminary Report on Patentability PCT/US2020/053902; dated Apr. 14, 2022, 5 pages. |
International Preliminary Report on Patentability PCT/US2020/036965; dated Dec. 23, 2021, 8 pages. |
International Preliminary Report on Patentability PCT/US2020/051228; dated Mar. 31, 2022, 9 pages. |
EP Application No. 18756031.3, EP Communication dated Oct. 4, 2021, 11 pages. |
Number | Date | Country | |
---|---|---|---|
20180103985 A1 | Apr 2018 | US |
Number | Date | Country | |
---|---|---|---|
62409448 | Oct 2016 | US |